Page 136 - Pharmacy Appeals 1/4/04 to 31/3/05
P. 136
112 Financial statements
Statement of comprehensive net
expenditure for the year ended
31 March 2022
Comprehensive net expenditure Notes 31 March Restated' 31 March
2022 2021
£000 £000
Other operating income 3 (2,525,620) (2,309,526)
Total operating income (2,525,620) (2,309,526)
Staff costs 2 33,445 26,446
Purchase of goods and services 2 7,042 6,247
Depreciation and impairment charges 2 886 934
Provision expense 7 45,418,628 155,363
Other operating expenditure 2 2,830 1,813
Total operating expenditure 45,462,831 190,803
Net operating expenditure 42,937,211 (2,118,723)
Finance expenditure 7 347,620 503,375
Net expenditure for the year 43,284,831 (1,615,348)
Comprehensive net expenditure for the year 43,284,831 (1,615,348)
The Notes on pages 118 to 156 form part of these financial statements.
The 2020/21 restatement is a decrease in the provision expense of £333 million to reflect a prior period adjustment for 2020/21
in respect of the revaluation of the known claims provision. See Note 7.4 for further details of the revaluation.
